List of Oncology Medication For

Lymphoma

The treatment of lymphoma depends on several factors, including the type and stage of the cancer, the patient’s age and overall health, and other individual factors. Treatment options may include: Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Stem cell transplantation.

If Blood Cancer – Lymphoma Medicines are not yet approved or available in your area, you may give a request, to get access price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

ENSACOVE (ensartinib) capsules

Lung Cancer, Lymphoma, Solid Tumors

Brand: ENSACOVE. API: ensartinib is used to treat anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC).

Ensacove (generic name: ensartinib) is a prescription kinase inhibitor used to treat adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) who have not previously received an ALK inhibitor.

Brand Name:	ENSACOVE – On Request
Generic Name:	ensartinib
Strength:	Capsules: 25 mg and 100 mg of ensartinib
Manufacturer:	Xcovery Holdings, Inc.
Approved By:	EMA, USFDA
Get access to medicines:	In India
Price:	On Request

See full prescribing information for ENSACOVE : Patient Information

Get access ENSACOVE to treat anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) on a Named Patient Import Basis.

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to ENSACOVE (ensartinib) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.

EPKINLY (epcoritamab-bysp) injection

Lymphoma, Immunotherapy

EPKINLY (epcoritamab-bysp) injection, for subcutaneous use Initial U.S. Approval: 2023

EPKINLY is a prescription medicine used to treat adults with certain types of diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma that has come back or that did not respond to previous treatment after receiving 2 or more treatments. EPKINLY is approved based on patient response data.

Brand Name:	EPKINLY
Generic Name:	epcoritamab-bysp
Strength:	• Injection: 4 mg/0.8 mL in a single-dose vial. Dilute prior to use. • Injection: 48 mg/0.8 mL in a single-dose vial.
Manufacturer:	Genmab US, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “EPKINLY (epcoritamab-bysp) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for EPKINLY (epcoritamab-bysp) injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

EPKINLY (epcoritamab-bysp) injection

Lymphoma, Immunotherapy

Brand Name: EPKINLY Generic Name: (epcoritamab-bysp). EPKINLY (epcoritamab-bysp) is used to treat lymphoma.

Epcoritamab-bysp is approved to treat adults with: Diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma. Follicular lymphoma.

Brand Name:	EPKINLY
Generic Name:	epcoritamab-bysp
Strength:	• Injection: 4 mg/0.8 mL in a single-dose vial. Dilute prior to use. • Injection: 48 mg/0.8 mL in a single-dose vial.
Manufacturer:	Genmab US, Inc
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “EPKINLY (epcoritamab-bysp)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for EPKINLY (epcoritamab-bysp) cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

JAYPIRCA (pirtobrutinib) tablets

Lymphoma, Blood Disorders, Solid Tumors

Brand Name: JAYPIRCA Generic Name: pirtobrutinib JAYPIRCA (pirtobrutinib) is used for treatment of Adult patients with relapsed or refractory mantle cell lymphoma (MCL)

Jaypirca is a cancer medicine used to treat adults with mantle cell lymphoma (a cancer of B cells, a type of white blood cell) whose cancer has come back (relapsed) or no longer responds to treatment (refractory), and who had previously received a type of cancer medicine called a Bruton’s tyrosine kinase (BTK) inhibitor.

Brand Name:	JAYPIRCA
Generic Name:	pirtobrutinib
Strength:	Tablets: 50 mg, 100 mg
Manufacturer:	Eli Lilly and Company
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “JAYPIRCA (pirtobrutinib)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for JAYPIRCA (pirtobrutinib) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

JYLAMVO (methotrexate) oral

Arthritis, Leukemia, Lymphoma

Brand Name: JYLAMVO Generic Name: methotrexate . JYLAMVO (methotrexate) is used to treat ALL, mycosis fungoides, nonHodgkin lymphoma, rheumatoid arthritis and severe psoriasis.

JYLAMVO is a folate analog metabolic inhibitor indicated for the: • Treatment of adults with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen • Treatment of adults with mycosis fungoides • Treatment of adults with relapsed or refractory nonHodgkin lymphoma as part of a metronomic combination regimen • Treatment of adults with rheumatoid arthritis • Treatment of adults with severe psoriasis.

Brand Name:	JYLAMVO
Generic Name:	methotrexate
Strength:	Oral solution: 2 mg/mL
Manufacturer:	Therakind Limited
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “JYLAMVO (methotrexate)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for JYLAMVO (methotrexate) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Lenalidomide Capsules

Multiple Myeloma, Lymphoma

lenalidomide capsules
for oral use Initial US Approval: 2005

Facts about lenalidomide capsules

Approval Date: 2005
Proprietary Name: On Request
Active Ingredient(s): Lenalidomide
Dosage Forms And Strengths: Capsules: 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg
Company: Bristol Myers Squibb
Diseases: Multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, follicular lymphoma and marginal zone lymphoma. It is used also in patients with myelodysplastic syndrome associated with a deletion 5q cytogenetic abnormality.
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “lenalidomide capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

loncastuximab tesirine-lpyl for injection

Lymphoma

loncastuximab tesirine-lpyl for injection
for intravenous use Initial U.S. Approval: 2021

Zynlonta (loncastuximab tesirine-lpyl) is a prescription medicine used to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after at least 2 prior systemic therapies.

Facts about loncastuximab tesirine-lpyl for injection

Disease Indications-Lymphoma
Manufacturer-ADC Therapeutics
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “loncastuximab tesirine-lpyl for injection” based on the information you provide.

luspatercept-aamt for injection

Lymphoma

luspatercept-aamt for injection
for subcutaneous use Initial U.S. Approval: 2019

Reblozyl (luspatercept) is a medication used for the treatment of adults with anemia (low red blood cells) associated with beta thalassemia or myelodysplastic syndromes.

Facts about luspatercept-aamt for injection

DISEASE INDICATIONS-Lymphoma
Dosage Forms and Strengths: For injection: 25 mg lyophilized powder in a single-dose vial for reconstitution (3) For injection: 75 mg lyophilized powder in a single-dose vial for reconstitution.
MANUFACTURER-Bristol-Myers Squibb
USAGE-Subcutaneous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “luspatercept-aamt for injection” based on the information you provide.

Mogamulizumab-kpkc Injection

Lymphoma

mogamulizumab-kpkc injection
for intravenous use Initial U.S. Approval: 2018

Poteligeo (mogamulizumab) is a medication used to treat adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy.

Facts about mogamulizumab-kpkc injection

Disease Indications-Lymphoma
Manufacturer-Kyorin Pharmaceuticals Co
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Mogamulizumab-kpkc Injection” based on the information you provide.

Nelarabine Injection

Lymphoma

Nelarabine Injection
for intravenous use Initial U.S. Approval: : 2005

Nelarabine is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. This use is based on the induction of complete responses. Randomized trials demonstrating increased survival or other clinical benefit have not been conducted.

Facts about Nelarabine Injection

Approval Date: 2005
Proprietary Name: On Request
Active Ingredient(s): Nelarabine Injection
Dosage Forms And Strengths:
Manufacturer:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Nelarabine Injection” based on the information you provide.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Lymphoma

Brand: ENSACOVE. API: ensartinib is used to treat anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC).

Get access ENSACOVE to treat anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) on a Named Patient Import Basis.

EPKINLY (epcoritamab-bysp) injection, for subcutaneous use Initial U.S. Approval: 2023

Brand Name: EPKINLY Generic Name: (epcoritamab-bysp). EPKINLY (epcoritamab-bysp) is used to treat lymphoma.

Brand Name: JAYPIRCA Generic Name: pirtobrutinib JAYPIRCA (pirtobrutinib) is used for treatment of Adult patients with relapsed or refractory mantle cell lymphoma (MCL)

Brand Name: JYLAMVO Generic Name: methotrexate . JYLAMVO (methotrexate) is used to treat ALL, mycosis fungoides, nonHodgkin lymphoma, rheumatoid arthritis and severe psoriasis.

lenalidomide capsules for oral use Initial US Approval: 2005

Facts about lenalidomide capsules

Access the best support services globally

loncastuximab tesirine-lpyl for injection for intravenous use Initial U.S. Approval: 2021

Facts about loncastuximab tesirine-lpyl for injection

Access the best support services globally

luspatercept-aamt for injection for subcutaneous use Initial U.S. Approval: 2019

Facts about luspatercept-aamt for injection

Access the best support services globally

mogamulizumab-kpkc injection for intravenous use Initial U.S. Approval: 2018

Facts about mogamulizumab-kpkc injection

Access the best support services globally

Nelarabine Injection for intravenous use Initial U.S. Approval: : 2005

Facts about Nelarabine Injection

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

lenalidomide capsules
for oral use Initial US Approval: 2005

loncastuximab tesirine-lpyl for injection
for intravenous use Initial U.S. Approval: 2021

luspatercept-aamt for injection
for subcutaneous use Initial U.S. Approval: 2019

mogamulizumab-kpkc injection
for intravenous use Initial U.S. Approval: 2018

Nelarabine Injection
for intravenous use Initial U.S. Approval: : 2005